Morton Freytag

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

|Nov 04, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer.

Neele Heckmann, Henning Plage, Ronald Simon

|Aug 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.

Viktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis

|Apr 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas.

Natalia Gorbokon, Katharina Teljuk, Viktor Reiswich

|Apr 02, 2025
Reduced occludin expression is related to unfavorable tumor phenotype and poor prognosis in many different tumor types: A tissue microarray study on 16,870 tumors.

Seyma Büyücek, Florian Viehweger, Viktor Reiswich

Pageof 1

Frequent Collaborators

5 joint publications

Ronald Simon

5 joint publications

Maximilian Lennartz

3 joint publications

David Dum

3 joint publications

Claudia Hube-Magg